鉴定基于基因的新型风险评分,用于前列腺癌的预后

Huangwei Huang1,2,3,4, Xia Sun3,5, Peixin Li1,4

  • 1Department of Urology, Cheeloo College of Medicine, Qilu Hospital, Shandong University, Jinan, Shandong, China.

Scientific reports
|July 1, 2025
PubMed
概括

一个新的六基因小组准确地分类前列腺癌风险,识别具有不良预后和较低免疫活性的高风险患者. 这种工具有助于个性化治疗和免疫疗法选择.